These results generated the hypothesis that protein expression and mRNA levels of the most important effectors of the IGFR pathway may be associated with clinical outcome in patients with early laryngeal cancer and may thus serve as predictive biological markers of relapse and survival in this setting. This evidence concerns the gene IGF1R and laryngeal carcinoma.